Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dingzhi Wuyou granule
- Development stage
- Unknown
- Lead developer
- Xuanwu Hospital
- Administration
- Oral
01
Overview
Dingzhi Wuyou granule is a Traditional Chinese Medicine (TCM) herbal formula developed by Xuanwu Hospital of Capital Medical University for the treatment of generalized anxiety disorder (GAD). In the context of TCM, it is designed to 'settle the mind' (Dingzhi) and alleviate worry (Wuyou), typically targeting syndromes such as heart and gallbladder qi deficiency or heart and spleen deficiency. The formulation has been evaluated in clinical trials in China, including studies aimed at optimizing TCM regimens for GAD by comparing various syndrome-specific formulae against standard pharmacological treatments like buspirone.
- Other names
- Dingzhi Wuyou Keli定志无忧颗粒
Beyond the preview
Go deeper on Dingzhi Wuyou granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dingzhi Wuyou granule.